Phase III randomised, double-blind, placebo-controlled study of Sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation trial.

  • Palmer, Daniel (Principal Investigator)

Project Details

Short titlePhase III randomised, double-blind, placebo-controlled study of Sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation trial.
StatusFinished
Effective start/end date1/04/0931/03/16

Funding

  • Queen Elizabeth Hospital Birmingham